FindTrial
Sign In

Analysis of biological and imaging markers in the process of immune-associated kidney disease

Analysis of biological and imaging markers in the process of immune-associated kidney disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020263
Enrollment
Unknown
Registered
2018-12-21
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune-associated kidney disease

Interventions

Case series:No

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with immune-associated kidney disease (ANCA-associated vasculitis, anti-GBM antibody nephritis, IgG4-related nephropathy, lupus nephritis, IgA nephropathy, purpura nephritis, etc.) 2. Aged between 18 and 80

Exclusion criteria

Exclusion criteria: 1. Early pregnancy within the first three months of pregnancy 2. Psychiatric patients

Design outcomes

Primary

MeasureTime frame
Immunometabonomics;Kidney tissue specific staining analysis;—

Secondary

MeasureTime frame
Imaging examination and multigroup examination;—

Countries

China

Contacts

Public ContactShen-Ju Gou

West China Hospital, Sichuan University

goushenju@163.com+86 18583991100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026